Related Experiment Videos
Aspergillus and other fungi
1Division of Cardiovascular and Thoracic Surgery, H. Lee Moffitt Cancer Center, University of South Florida College of Medicine, Tampa, USA. robinson@moffitt.usf.edu
Abstract:
Opportunistic infections that arise in the immunocompromised host are a major cause of morbidity and mortality. Although bacterial infections are more frequent, invasive fungal infections occur commonly and carry higher risks in these immunocompromised patients. Newer antifungal agents, along with an occasional pulmonary resection, have improved the treatment options and the survival from invasive fungal infections in immunocompromised patients.
Insights
Invasive fungal infections pose significant risks to immunocompromised patients. Advances in antifungal therapies and surgical interventions are improving treatment outcomes and survival rates for these serious infections.
Area of Science:
- Medical Mycology
- Immunocompromised Host Research
- Infectious Diseases
Background:
- Opportunistic infections are a primary cause of illness and death in immunocompromised individuals.
- While bacterial infections are more common, invasive fungal infections present a substantial risk and higher mortality in this population.
- Effective management strategies for invasive fungal infections are crucial for improving patient survival.
Purpose of the Study:
- To review the current landscape of invasive fungal infections in immunocompromised hosts.
- To highlight the impact of newer antifungal agents and surgical options on patient outcomes.
- To underscore the importance of timely and appropriate treatment for these infections.
Main Methods:
- Literature review of recent studies on invasive fungal infections.
- Analysis of treatment outcomes with novel antifungal therapies.
- Evaluation of the role of pulmonary resection in managing fungal infections.
Main Results:
- Invasive fungal infections contribute significantly to morbidity and mortality in immunocompromised patients.
- Newer antifungal agents have demonstrated improved efficacy in treating these infections.
- Surgical interventions, such as pulmonary resection, can be beneficial in select cases.
Conclusions:
- Invasive fungal infections remain a critical concern for immunocompromised patients.
- Advancements in antifungal pharmacotherapy offer better therapeutic options.
- A combination of medical and surgical approaches can enhance survival rates.